Showing results (401-410 of 611) with videos related to
Sort By:
Pageof 62
Applied Pathology|January 1, 1989
Relationship between progesterone receptor, axillary node status and productive fibrosis in ductal infiltrating carcinoma of the breastC Giani, D Campani, F De Negri, et al.Fertility and Sterility|December 1, 1987
Induction of ovulation by intermittent intravenous purified follicle-stimulating hormone in polycystic ovarian diseaseA Lanzone, A M Fulghesu, M Conte, et al.Molecular and Cellular Probes|March 24, 2004
Primer extension assay for prion protein genotype determination in sheepG Vaccari, M Conte, L Morelli, et al.La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|January 1, 1995
[Status asthmaticus]G G Viviano, M Conte, C P Benedetto, et al.Epilepsia|December 10, 2014
Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestryRyan L Subaran, Juliette M Conte, William C L Stewart, et al.Revue Francaise De Gynecologie Et D'Obstetrique|October 1, 1985
[Pregnancy and childbirth in the North African woman]J Adrai, B Blanc, H Ruf, et al.Annals of the New York Academy of Sciences|January 1, 1986
Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' diseaseL D Kohn, F Alvarez, C Marcocci, et al.Journal of Endocrinological Investigation|June 21, 2018
Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory studyG Lanzolla, E Sabini, M A Profilo, et al.Journal of Endocrinological Investigation|January 19, 2015
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapyE Sisti, F Menconi, M Leo, et al.Journal of Endocrinological Investigation|December 16, 2014
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNETM Lombardi, N De Lio, N Funel, et al.Pageof 62